Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden

Background. Doxorubicin/ifosfamide is a first-line systemic chemotherapy for the majority of advanced soft tissue sarcoma (ASTS) subtypes. Trabectedin is indicated for the treatment of ASTS after failure of anthracyclines and/or ifosfamide; however it is being increasingly used off-label as a first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Guest, Julian F., Panca, Monica, Sladkevicius, Erikas, Gough, Nicholas, Linch, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835776/
https://www.ncbi.nlm.nih.gov/pubmed/24302852
http://dx.doi.org/10.1155/2013/725305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835776/
https://www.ncbi.nlm.nih.gov/pubmed/24302852
http://dx.doi.org/10.1155/2013/725305

Ejemplares similares